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Abstract 
This research work investigates the long term in vitro degradation behavior of alginate-aloe vera composite membranes for skin 
regeneration. The membranes were prepared through a two-step procedure, which involves the synthesis of thin membranes and 
the crosslinking reaction. Degradation tests were performed through the immersion of the membranes into simulated body fluid 
solution at pH 7.4 and physiological temperature, during 6 months. Alginate-aloe vera membranes are resistant to the hydrolytic 
degradation and exhibit weight loss values in a range of 20.37-26.32%. Results show that an increase in the aloe vera content 
leads to a slight increase in the weight loss during the degradation process. Preliminary drug release studies, using nitrofurazone 
as a model drug, suggest the ability of the developed membranes to be used as a drug delivery system. 
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1. Introduction 
The regeneration of skin remains a huge challenge for the clinicians, due to its multilayer structure and the 
presence of multiple cell types in a well-organized way. In order to promote the regeneration of healthy skin, 
several therapies (traditional and advanced) and biomaterials have been developed and used. Traditional therapies 
involve, for example, the use of medicinal plants, honey, larval therapies and gauzes (Jin et al. 2013; Sell et al. 
2012; Turkmen et al. 2010). Despite the reduced costs of these therapies, they have been replaced by advanced 
ones, which include the use of wound dressings, tissue-engineered skin substitutes, cellular therapies and in situ 
biofabrication approaches (Pereira et al. 2013a; Wu et al. 2007). In advanced therapies, either natural or synthetic 
polymers play a pivotal role, enabling the development of either 2D or 3D matrices that mimic the function of the 
natural extracellular matrix (ECM) and support the repair and regeneration of the new tissue (Melchels et al. 2012). 
Biopolymers represent a class of materials obtained from the nature that have been widely used in the field of 
tissue engineering and regenerative medicine, due to its useful properties such as the biocompatibility, 
biodegradability, hydrogel formation and compositional similarities with the ECM of the human tissues (Van 
Vlierberghe et al. 2011). Alginate is a natural polymer obtained from brown algae that contains -D-mannuronic 
acid and -L-guluronic acid units in its chemical composition (Pereira et al. 2011; Rezende et al. 2009). This 
material has the ability to easily form hydrogels in mild conditions without the use of toxic solvents, for example, 
through the interaction with divalent and trivalent cations (Pereira et al. 2013b). As a result of the high water 
content, elasticity, permeability and ability to create a moist environment in the wound bed, alginate-based 
hydrogels have been processed into different physical forms like films (Pereira et al. 2013c), scaffolds (Kim et al. 
2011) and nanofibers (Shalumon et al. 2011) for skin applications.  
In recent years, the use of medicinal plants as topical agents to induce the regeneration of different types of skin 
lesions has been increasing. Aloe vera is tropical plant composed of a water fraction and a solid fraction, containing 
potentially therapeutic constituents such as soluble sugars, lipids, proteins, polysaccharides, glycoproteins, vitamins 
and minerals (Boudreau and Beland, 2006). Due to its therapeutic properties, which include the anti-inflammatory, 
antibacterial and ability to improve the collagen content and the blood vessel formation during the healing process, 
aloe vera has been used as therapeutic agent to promote the skin repair (Pellizzoni et al. 2012; Atiba et al. 2011; 
Boudreau and Beland, 2006). 
In this work, we investigate the in vitro degradation behavior of alginate-aloe vera membranes for skin tissue 
engineering applications. Preliminary drug release studies are also performed to evaluate the ability of the 
membranes to act as a drug delivery system. 
2. Materials and methods 
2.1. Materials 
Sodium alginate (BDH Prolabo, VWR International, UK) was used with 54.09 ± 1% of M units, determined by 
1H NMR (Pereira et al. 2013b). The aloe vera (ACTIValoe®, Aloe vera Gel Qmatrix 200X Flakes) was kindly 
offered by Aloecorp (Broomfield, U.S.A.) and the glycerol was obtained from Scharlau (Spain). Calcium chloride 
and the drug nitrofurazone (NFZ) were obtained from Sigma Aldrich (Portugal). All other chemicals were reagent 
grade and used as received. 
2.2. Preparation of biopolymer-based membranes 
Membranes were prepared using a two-step experimental protocol previously developed (Pereira et al. 2013b). 
In the first step, aqueous solutions of aloe vera (1.0% w/v) and sodium alginate (1.5% w/v) containing 15% of 
glycerol were mixed at 600 rpm during 30 min, in order to obtain different alginate-aloe vera proportions, as 
shown in Table 1. Afterwards, the solutions (25 mL) were casted into the petri dishes (9.5 cm of diameter) and 
allowed to dry at 25ºC. In the second step, the dry membranes were immersed into a calcium chloride aqueous 
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solution (5.0%, w/v) for 5 minutes to allow the formation of hydrogel membranes. Then, the membranes were 
extensively washed with distilled water and dried at room temperature until constant weight.  
To prepare drug-loaded membranes, nitrofurazone was added to the alginate solution at a concentration of 0.2 
mg/mL, during preparation. The obtained membranes were designated as AG/NFZ, AGA5/NFZ, AGA15/NFZ and 
AGA25/NFZ. 
Table 1. Composition of the composite membranes prepared using alginate, aloe vera and glycerol 
Membrane abbreviation 
Membrane composition (v/v) 
Alginate (1.5% w/v) Glycerol (%, w/w based on the alginate mass) Aloe vera (1.0% w/v) 
AG 100 15 0 
AGA5 95 15 5 
AGA15 85 15 15 
AGA25 75 15 25 
2.3. In vitro degradation behavior of membranes 
The degradation behavior of the biopolymer-based membranes was investigated by the immersion of 
rectangular samples (50 mm x 15 mm) into a falcon tube containing 10 mL of simulated body fluid (SBF) solution 
at pH 7.4. The tubes were incubated at 37ºC during 24 weeks. Prior to test, the samples were dried in an oven at 
37ºC until constant mass. The specimens were removed from the medium at defined time periods and the excess of 
water at the surface was withdrawn using a filter paper. Then, the samples were immediately weighted to 
determine the water uptake, and subsequently dried in an oven at 37ºC until constant mass to evaluate its weight 
loss. The medium was replaced weekly with fresh solution. Nine samples were used for each condition. 
2.3.1. Thickness change, water uptake and weight loss  
 
The thickness of the membranes in dry state was evaluated using a micrometer (Model 102-301, Mitutoyo) with 
0.001 mm of accuracy before and after the degradation process.  
The water uptake during the degradation process was determined by dividing the wet weight of the membrane 
after immersion by the initial dry weight before immersion, while the membrane’s weight loss was calculated as 
follows: 
 
100
i
fi
W
WW
lossWeight          (1) 
 
where, Wf represent the dry weight of the membrane after degradation and Wi correspond to the dry weight of 
the membrane before the degradation process. 
2.4. In vitro drug release studies 
To investigate the properties of the membranes for drug delivery applications, drug-loaded membranes (30 mm 
x 30 mm) were incubated into acetate buffer (30 mL) at physiological temperature and 100 rpm (Siewert et al. 
2003). At pre-determined periods of time, a sample of the medium was collected and the amount of the released 
drug was quantified using an UV spectrophotometer (Genesys 10UV) at 365 nm. Three replicates were tested for 
each condition. 
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3. Results and discussion 
Alginate-based membranes were successfully prepared using aloe vera contents between 5% and 25%. The 
membranes exhibit high transparency in both dry and wet state, good homogeneity and a homogeneous surface.   
3.1. In vitro degradation behavior  
The degradation behaviour of biomaterials for tissue regeneration is a critical property, strongly influencing the 
regeneration rate of the new tissue (Alsberg et al. 2003). The degradation tests were carried out in SBF solution at 
37ºC to investigate both the influence of the aloe vera content and the durability of the membranes in aqueous 
environment.  
Fig. 1a shows the weight loss profiles of the alginate-aloe vera membranes along the degradation time. All 
membranes exhibit a quick loss of weight during the first week, which is attributed to the leaching of the plasticizer 
and/or the release of aloe vera compounds. After this stage, membranes present a slower and gradual loss of weight 
during the next weeks, reaching weight loss values comprised between 20.37 ± 0.94% and 26.32 ± 1.75%, after 24 
weeks of incubation. From Fig. 1a, it is also possible to verify that the increase in aloe vera content leads to a slight 
increase in the weight loss. The influence of the aloe vera content in the degradation rate of membranes is 
explained by the differences in water absorption, as shown in Fig. 1b. The membranes with high aloe vera 
percentage present a significant increase in the water uptake during the degradation process due to the hydrophilic 
properties of aloe vera (Pereira et al. 2013b). Similarly to the weight loss profiles, the water absorption results 
indicate that the use of 5% of aloe vera does not have significant influence in the water uptake, while 15% and 
25% of aloe vera strongly improve the water absorption. Based on these results, it is expected that the further 
penetration of water molecules within the membranes with high aloe vera content leads to an increase in the 
cleavage of degradable linkages, which in turn improves the weight loss (Fig. 1c). 
 
  
  
Fig. 1. (a) Weight loss and (b) water absorption profiles of the alginate-aloe vera membranes during the degradation process; (c) illustration of 
the degradation process with cleavage of degradable bonds and consequent release of calcium ions and aloe vera compounds in the lesion site. 
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Fig. 2a displays the changes in the wet thickness of the membranes during the degradation process. Results 
show that the membranes with high aloe vera contents suffer a great increase in the thickness values in the first 
weeks of degradation, which is in accordance with the water absorption data. Along the incubation time, the dry 
weight of the membranes was also monitored as an indicator of the degradation process. Dry membranes exhibit a 
great reduction in their thickness during the first 10 weeks of degradation, which is followed by a slow and gradual 
reduction during the following 14 weeks (Fig. 2b). After 24 weeks of degradation, the thickness of the membranes 
shows a reduction in a range of 33.8-38.5%.  
 
  
Fig. 2. Changes in the wet (a) and dry (b) thickness of the membranes at different periods of degradation. 
3.2. Drug release studies 
The ability of the membranes to act as a drug delivery system is very important for skin tissue engineering, 
enabling the topical release of aloe vera compounds and other therapeutic agents directly into the lesion site. The 
drug release tests were performed using nitrofurazone as a model drug and acetate buffer to simulate the skin pH.  
The drug-loaded membranes exhibit a yellowish coloration due to the incorporation of nitrofurazone, 
maintaining a good transparency. During the crosslinking process, the drug diffused from the membranes to the 
crosslinking solution, leading to a decrease in the incorporation efficiency. The amount of drug lost during the 
crosslinking process is comprised between 3.61% and 7.95%, being dependent on the film composition (membrane 
AG/NFZ: 3.61 ± 0.64%; AGA5/NFZ: 3.66 ± 0.10%; AGA15/NFZ: 6.39 ± 3.99%; AGA25/NFZ: 7.95 ± 2.12%). 
Fig. 3 shows the influence of the membrane composition in the drug release kinetics. From the results, it is 
possible to observe that the drug release increases as the aloe vera content within the membranes also increases. 
All profiles are characterized by an instantaneous release of drug (burst release) due to the diffusion of the particles 
located at the surface of the membrane. The control membrane (AG/NFZ) and the membrane containing 5% of 
aloe vera (AGA5/NFZ) present a reduced percentage of drug released along the experiment, which is due to the 
differences in the water absorption. The increase in aloe vera content leads to a significant increase in the water 
absorption, causing a higher diffusion of the drug for the medium. The membranes containing 15% and 25% of 
aloe vera release the incorporated drug in approximated 120 min, while the remaining films release about 80% of 
the drug at the same period of time. 
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Fig. 3. Release profiles of the drug-loaded membranes immersed into acetate buffer at pH 5.5. 
4. Conclusions 
Biopolymer-based membranes, composed of alginate, aloe vera and glycerol, were prepared and its degradation 
behavior investigated. Long term in vitro degradation tests performed in SBF solution show that the membranes 
are resistant to the hydrolytic degradation, while aloe vera slightly improves the loss of weight during the 
incubation time. Preliminary in vitro drug release tests suggest that the membranes are able to incorporate and 
release drugs.  
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